Disclaimer
Acetadote is an ethical pharmaceutical that has been approved and is regulated by the Food and Drug Administration (FDA). Acetadote can be obtained only by prescription from a licensed healthcare provider after diligent disclosure by the healthcare provider.
The information provided in this website, directory, accompanying articles, and links to other related websites is provided as a courtesy to site visitors, and all material is intended for information, communication, and education purposes only, and is in no manner an endorsement, recommendation or approval of anyone, any product, or treatment. The information presented is not to be considered complete, nor does it contain all medical information that may be relevant, and therefore is not intended as a substitute for seeking medical treatment and/or appropriate care, nor is the information intended to replace medical advice offered by physicians and should not be construed as rendering medical advice.
INDICATION
Acetadote is an antidote for acetaminophen overdose indicated to prevent or lessen hepatic injury after ingestion of a potentially hepatotoxic quantity of acetaminophen in patients with an acute ingestion or from repeated supratherapeutic ingestion.
IMPORTANT SAFETY INFORMATION
ADVERSE EVENTS
In the literature, the most frequently reported adverse reactions attributed to intravenous acetylcysteine administration were rash, urticaria and pruritus. The frequency of adverse reactions have been reported to be between 0.2% and 21%, and they most commonly occur during the initial loading dose of acetylcysteine.